| Cash Flow | 2025-06-30 |
|---|---|
| Stock-based compensation | 28,708,643 |
| Allowance for credit losses | 200,454 |
| Net loss | -39,103,367 |
| Prepaid expenses | 65,001 |
| Other assets | -332 |
| Operating lease liabilities, net | -5,720 |
| Inventories | -487,465 |
| Accrued expenses and other liabilities | 1,145,749 |
| Accounts receivable | -362,911 |
| Accounts payable | 3,141,897 |
| Depreciation | 79,538 |
| Amortization | 1,526,129 |
| Due from / to related parties, net | -61,112 |
| Deposits | 0 |
| Amortization of debt discount | 33,411 |
| Net cash (used in) provided by operating activities | -3,426,447 |
| Investments in capitalized software | 405,059 |
| Cash acquired in business combinations | 0 |
| Net cash used in investing activities | -405,059 |
| Repayment of seller promissory note | 137,141 |
| Proceeds from revolving line of credit | 17,146,000 |
| Proceeds from term loan | 703,366 |
| Proceeds from common stock issued pursuant to equity purchase agreement | 567,722 |
| Proceeds from promissory note | 615,000 |
| Proceeds from common stock issued pursuant to public offering | 4,000,000 |
| Repayments of revolving line of credit | 18,697,494 |
| Proceeds from merchant cash advance | 234,157 |
| Offering costs | -1,208,498 |
| Founders initial contribution | 0 |
| Net cash provided by (used in) financing activities | 3,223,112 |
| Net change in cash and cash equivalents | -608,394 |
Wellgistics Health, Inc. (WGRX)
Wellgistics Health, Inc. (WGRX)